Nifty

:

24213.30

Sensex

:

79476.63

217.95 (0.91%)
694.39 (0.88%)

Login

Nifty
Sensex

:
:

24213.30
79476.63

217.95 (0.91%)
694.39 (0.88%)

Adeshwar Meditex Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 543309 | NSE: Not Listed

Watchlist

NSE BSE

25

04-Nov-2024

Open
High
Low
Previous Close

26.5
26.5
24.3
24.00

Volume
Traded Value (lacs)
52 Week High
52 Week Low

30000
759000
36.00
20.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

36.08
17.97
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

48.81
N/A
1.03

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
-

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

-

P:BV (Average)

8 Years
5 Years
3 Years

-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 14 Mar 13 Mar 12
Net Sales - 79.85 82.36 64.76 65.97 56.12 52.92 58.60 16.41 26.66 13.67 Net Sales Growth - -3.05% 27.18% -1.83% 17.55% 6.05% -9.69% 257.10% -38.45% 95.03% Cost Of Goods Sold - 69.81 69.50 54.89 54.66 42.21 43.67 47.92 -0.49 20.98 9.00 Gross Profit - 10.04 12.86 9.86 11.31 13.90 9.25 10.69 16.89 5.68 4.67 GP Margin - 12.57% 15.61% 15.23% 17.14% 24.77% 17.48% 18.24% 102.93% 21.31% 34.16% Total Expenditure - 74.67 77.14 61.36 61.26 50.63 49.04 53.08 14.47 24.33 12.30 Power & Fuel Cost - 0.04 0.06 0.20 0.21 0.00 0.00 0.00 0.00 0.00 0.00 % Of Sales - 0.05% 0.07% 0.31% 0.32% 0% 0% 0% 0% 0% 0% Employee Cost - 1.16 1.33 1.33 1.51 1.17 2.26 1.87 0.00 1.20 0.78 % Of Sales - 1.45% 1.61% 2.05% 2.29% 2.08% 4.27% 3.19% 0% 4.50% 5.71% Manufacturing Exp. - 0.96 1.28 0.95 0.60 2.10 0.00 0.00 0.00 0.93 1.12 % Of Sales - 1.20% 1.55% 1.47% 0.91% 3.74% 0% 0% 0% 3.49% 8.19% General & Admin Exp. - 2.18 2.92 2.08 2.22 2.91 3.10 3.30 14.06 0.56 0.86 % Of Sales - 2.73% 3.55% 3.21% 3.37% 5.19% 5.86% 5.63% 85.68% 2.10% 6.29% Selling & Distn. Exp. - 0.45 1.99 1.80 1.92 2.24 0.00 0.00 0.89 0.66 0.55 % Of Sales - 0.56% 2.42% 2.78% 2.91% 3.99% 0% 0% 5.42% 2.48% 4.02% Miscellaneous Exp. - 0.07 0.06 0.11 0.14 0.00 0.00 0.00 0.00 0.00 0.55 % Of Sales - 0.09% 0.07% 0.17% 0.21% 0% 0% 0% 0% 0% 0% EBITDA - 5.18 5.22 3.40 4.71 5.49 3.88 5.52 1.94 2.33 1.37 EBITDA Margin - 6.49% 6.34% 5.25% 7.14% 9.78% 7.33% 9.42% 11.82% 8.74% 10.02% Other Income - 0.13 0.31 0.23 0.27 0.28 1.82 0.10 0.00 0.17 0.36 Interest - 1.93 2.09 2.05 2.29 2.52 2.23 1.66 0.55 0.35 0.20 Depreciation - 0.60 0.53 0.38 0.35 0.34 0.35 0.37 0.44 0.41 0.39 PBT - 2.79 2.90 1.19 2.34 2.91 3.12 3.58 0.95 1.74 1.13 Tax - 0.78 0.83 0.40 0.66 0.79 0.87 1.02 0.37 0.56 0.36 Tax Rate - 27.96% 28.62% 33.61% 28.21% 27.15% 27.88% 28.49% 38.95% 32.18% 31.86% PAT - 2.01 2.07 0.79 1.68 2.12 2.25 2.56 0.58 1.19 0.77 PAT before Minority Interest - 2.01 2.07 0.79 1.68 2.12 2.25 2.56 0.58 1.19 0.77 Minority Interest - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin - 2.52% 2.51% 1.22% 2.55% 3.78% 4.25% 4.37% 3.53% 4.46% 5.63% PAT Growth - -2.90% 162.03% -52.98% -20.75% -5.78% -12.11% 341.38% -51.26% 54.55% EPS - 1.40 1.44 0.55 1.17 1.47 1.56 1.78 0.40 0.83 0.53

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 14 Mar 13 Mar 12
Shareholder's Funds 34.91 32.91 30.95 20.58 18.90 15.80 13.55 5.50 4.69 2.51 Share Capital 14.43 14.43 14.43 10.53 5.27 4.98 4.98 2.85 2.00 0.57 Total Reserves 20.48 18.48 16.52 10.05 13.64 10.82 8.57 2.65 2.69 1.94 Non-Current Liabilities 1.26 2.62 4.41 5.76 6.62 5.66 1.25 3.43 2.62 1.86 Secured Loans 1.06 2.32 4.00 2.16 0.00 0.00 0.03 0.03 0.07 0.10 Unsecured Loans 0.00 0.00 0.07 3.20 6.13 5.00 0.52 2.22 1.49 0.69 Long Term Provisions 0.34 0.38 0.34 0.28 0.15 0.13 0.08 0.00 0.00 0.00 Current Liabilities 27.73 31.36 37.09 35.84 29.20 22.30 17.91 6.57 7.27 7.64 Trade Payables 14.53 16.79 20.83 17.95 12.71 6.85 5.99 3.14 4.00 4.86 Other Current Liabilities 1.31 2.18 2.99 2.71 1.22 0.48 0.99 0.72 0.75 0.58 Short Term Borrowings 11.73 12.21 13.17 15.04 15.19 14.92 10.92 2.60 2.46 2.12 Short Term Provisions 0.17 0.19 0.10 0.14 0.08 0.04 0.01 0.10 0.06 0.08 Total Liabilities 63.90 66.89 72.45 62.18 54.72 43.76 32.71 15.50 14.58 12.01 Net Block 3.53 3.70 3.03 2.24 2.28 2.42 2.35 3.23 3.28 3.25 Gross Block 10.16 9.73 8.53 7.35 7.03 6.85 6.42 5.55 5.16 4.72 Accumulated Depreciation 6.63 6.03 5.50 5.11 4.74 4.42 4.07 2.32 1.88 1.47 Non Current Assets 6.78 7.32 7.35 5.11 4.72 4.45 3.90 3.28 3.30 3.28 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Non Current Investment 0.10 0.10 0.10 0.08 0.08 0.04 0.02 0.00 0.00 0.00 Long Term Loans & Adv. 1.08 1.46 1.81 0.93 0.37 0.35 0.29 0.05 0.02 0.02 Other Non Current Assets 2.07 2.06 2.41 1.86 1.99 1.64 1.23 0.00 0.00 0.00 Current Assets 57.12 59.57 65.10 57.06 50.00 39.31 28.81 12.21 11.28 8.74 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 26.53 24.32 25.30 26.11 14.49 13.47 8.46 5.29 4.78 2.80 Sundry Debtors 25.27 27.93 32.48 27.26 27.87 19.64 17.45 3.84 3.80 3.42 Cash & Bank 1.16 1.90 1.92 1.07 1.73 1.39 1.34 0.21 0.14 0.19 Other Current Assets 4.17 0.39 0.54 0.60 5.92 4.81 1.56 2.87 2.56 2.33 Short Term Loans & Adv. 3.80 5.02 4.86 2.02 5.62 4.51 1.16 0.73 0.82 0.27 Net Current Assets 29.39 28.21 28.01 21.22 20.80 17.01 10.90 5.65 4.01 1.10 Total Assets 63.90 66.89 72.45 62.17 54.72 43.76 32.71 15.49 14.58 12.02

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 13 Mar 12
Cash From Operating Activity 3.84 5.77 -2.44 3.15 -0.99 -5.87 -1.17 0.00 0.00 PBT 2.79 2.90 1.19 2.34 2.91 3.12 3.58 0.00 0.00 Adjustment 2.19 2.32 2.28 2.35 2.80 2.44 1.94 0.00 0.00 Changes in Working Capital -0.33 1.48 -5.34 -0.83 -5.88 -10.56 -5.64 0.00 0.00 Cash after chg. in Working capital 4.65 6.70 -1.87 3.87 -0.17 -5.00 -0.12 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -0.81 -0.94 -0.56 -0.71 -0.82 -0.88 -1.05 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.22 -1.16 -1.16 -0.71 1.58 -0.30 0.07 0.00 0.00 Net Fixed Assets -0.43 -1.20 -1.18 -0.32 -0.18 -0.43 -1.26 -0.44 Net Investments 0.00 0.00 -0.02 0.00 -0.04 -0.02 -0.02 0.00 Others 0.21 0.04 0.04 -0.39 1.80 0.15 1.35 0.44 Cash from Financing Activity -4.36 -4.62 4.44 -3.11 -0.07 6.22 1.22 0.00 0.00 Net Cash Inflow / Outflow -0.75 -0.02 0.85 -0.66 0.53 0.05 0.11 0.00 0.00 Opening Cash & Equivalents 1.90 1.92 1.07 1.73 1.20 1.34 1.23 0.00 0.00 Closing Cash & Equivalent 1.16 1.90 1.92 1.07 1.73 1.38 1.34 0.00 0.00

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 24.19 22.81 21.45 19.54 35.90 31.72 27.20 19.30 23.45 43.78 ROA 3.07% 2.98% 1.18% 2.87% 4.30% 5.89% 10.63% 3.83% 8.93% 6.66% ROE 5.92% 6.50% 3.08% 8.50% 12.19% 15.34% 26.89% 11.31% 32.99% 41.04% ROCE 9.60% 10.06% 6.98% 11.13% 14.29% 17.59% 29.56% 15.72% 29.48% 32.84% Fixed Asset Turnover 8.03 9.02 8.16 9.17 8.09 7.98 9.79 3.06 5.40 3.09 Receivable days 121.60 133.88 168.39 152.53 154.51 127.89 66.30 85.01 49.42 78.19 Inventory Days 116.22 109.96 144.88 112.29 90.93 75.63 42.81 112.04 51.90 60.08 Payable days 81.86 98.77 128.91 102.36 71.32 48.31 32.58 680.36 64.15 172.37 Cash Conversion Cycle 155.96 145.07 184.36 162.46 174.11 155.21 76.53 -483.31 37.17 -34.10 Total Debt/Equity 0.40 0.50 0.61 1.09 1.13 1.26 0.86 0.89 0.86 1.17 Interest Cover 2.45 2.39 1.58 2.02 2.15 2.40 3.15 2.72 6.03 6.55

Top Investors:

ashalata b raut

amish rasik mehta huf

mahaveerprasad nandlal agarwal

baby dattatray chavan

amish rasiklal mehta

sharda rasiklal mehta

meghana tibrewala

neha amish mehta

aatmi amish mehta

Annual Reports:

News Update:

No Latest News!

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback